GLP Watchdog

Gala vs Push Health

Neither Gala nor Push Health has an FDA warning letter on record. Push Health publishes no GLP-1 price we could capture. Gala starts at $179 a month for compounded semaglutide injection.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Gala / Push Health

Featured pick (affiliate partner)

Gala logo

Gala

8.5/10

Push Health logo

Push Health

4.1/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
None named in our record
Lowest standing price
$179/moCompounded semaglutide injection
No GLP-1 price published
States
All 50 states
No state list published
Checked
Prices captured Record checked October 2026
Prices captured Record checked September 2026
Visit Gala
Visit Push Health

Gala is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Push Health pays us nothing. The scores are computed the same way for both and are shown as computed (Gala 8.5, Push Health 4.1). How we are paid

What the record shows

  1. 01

    Neither Gala nor Push Health has an FDA warning letter on record.

  2. 02

    Neither names the pharmacy that compounds its medication.

  3. 03

    Push Health publishes no GLP-1 price we could capture. Gala starts at $179 a month for compounded semaglutide injection.

  4. 04

    Only Gala lists a price for compounded semaglutide injection, compounded tirzepatide injection and brand-name semaglutide pen.

  5. 05

    Gala lists all 50 states. Push Health publishes no state list.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Gala

Push Health

Compounded semaglutide injection

$179/mo

$2,148 a year

Not sold or not priced
Compounded tirzepatide injection

$179/mo

$2,148 a year

Not sold or not priced
Brand-name semaglutide pen

$1,299/mo

$15,588 a year

Not sold or not priced
Price includes
Medication, clinician visits, shipping
Not stated
Cancel any time
Yes, stated
Yes, stated
Minimum term
Yearly plan for the $179 rate; 72 hours' notice before the billing date to cancel
None
Refunds
No refund on cancellation; full refund only if the medical provider disqualifies you
Full refund if you cancel before the provider writes a prescription; none after

Read off each seller’s own pages. Gala: October 17, 2026. Push Health: September 28, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Gala

8.5/10
Featured pick (affiliate partner)
  • Sells compounded semaglutide injection and compounded tirzepatide injection, which Push Health does not price
  • Names no compounding pharmacy
Visit Gala

The case for Push Health

4.1/10

The record gives Push Health no edge on this pair.

  • Names no compounding pharmacy
  • Publishes no state list
  • Publishes no GLP-1 price
Visit Push Health

Scores

Gala 8.5 · Push Health 4.1 out of 10. Six weighted parts.

Value25%

7.9A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
5.0

User Experience15%

8.0A
vs
B
3.0

Trust & Safety15%

7.5A
vs
B
4.0

Accessibility10%

10.0A
vs
B
5.0

Support10%

7.0A
vs
B
5.0

The score is the same formula for every seller. Payment does not enter it. Method

Gala vs Push Health: questions

Neither Gala nor Push Health has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Neither names the pharmacy that compounds its medication.
Gala states you can cancel at any time; refunds: no refund on cancellation; full refund only if the medical provider disqualifies you. Push Health states you can cancel at any time; refunds: full refund if you cancel before the provider writes a prescription; none after.
Gala is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Push Health pays us nothing. The scores are computed the same way for both and are shown as computed (Gala 8.5, Push Health 4.1).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks